Picture of Epirus Biopharmaceuticals logo

EPRSQ — Epirus Biopharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Epirus says Epirus Switzerland gmbh signed settlement agreement with Reliance Life Sciences

April 24 (Reuters) - EPIRUS Biopharmaceuticals Inc  EPRS.O : 
 * On April 22, 2015, Epirus Switzerland gmbh entered into a settlement 
   agreement with Reliance Life Sciences Pvt Ltd 
 * Settlement agreement resolves dispute initiated by RLS on scope of the 
   parties' manufacturing and supply agreement 
 * Pursuant to settlement agreement, RLS has agreed to manufacture 20 final 
   batches of the co's product, BOW015 
 * RLS has also agreed to use reasonable commercial efforts to transfer existing 
   Indian marketing authorization for BOW015 to co or its designee 
 
 * Source text for Eikon  ID:nEOLc4gc43  
 
 * Further company coverage  EPRS.O  
 
 ((Bengaluru Newsroom; +1 646 223 8780))

Recent news on Epirus Biopharmaceuticals

See all news